Literature DB >> 1715126

Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases.

Y Aratake1, T Kotani, K Tamura, Y Araki, T Kuribayashi, K Konoe, S Ohtaki.   

Abstract

Staining for dipeptidyl aminopeptidase IV (DAP IV [EC: 3.4.14.5]) activity was applied to aspiration biopsy specimens or imprint preparations of surgical biopsy specimens from thyroid tumors. Material was obtained from 55 patients with histologically proven thyroid diseases: 9 with papillary carcinoma, 5 with follicular carcinoma, 11 with follicular adenoma, 13 with adenomatous goiter, 8 with Hashimoto's thyroiditis, and 9 with other benign conditions. Most tumor cells, follicular lumina in cell clusters, and intranuclear inclusions were strongly positive for DAP IV in all examples of papillary or follicular carcinoma. In contrast, only a few epithelial cells were labeled for DAP IV in follicular adenoma and adenomatous goiter. Some Hürthle cells in Hashimoto's thyroiditis also were positive for DAP IV. When a DAP IV scoring system based on the percentage of positive cells and staining intensity was used, all benign tissues except one (from a follicular adenoma) were found to have extremely low scores. These results indicate that staining for DAP IV activity is a simple but useful tool to aid in distinguishing benign from malignant thyroid neoplasms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715126     DOI: 10.1093/ajcp/96.3.306

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  Decrease in dipeptidyl peptidase IV activity is linked to the efficacy of differentiating compounds in follicular thyroid carcinoma cell lines.

Authors:  E Fröhlich; E Engel; R Wahl
Journal:  Horm Metab Res       Date:  2011-03-16       Impact factor: 2.936

2.  Characterization of the prolyl dipeptidyl peptidase gene (dppIV) from the koji mold Aspergillus oryzae.

Authors:  A Doumas; P van den Broek; M Affolter; M Monod
Journal:  Appl Environ Microbiol       Date:  1998-12       Impact factor: 4.792

3.  Immunohistochemical localization of dipeptidyl aminopeptidase IV in thyroid papillary carcinoma.

Authors:  T Kotani; J Kawano; T Suganuma; K Hirai; K Umeki; Y Aratake; K Konoe; S Ohtaki
Journal:  Int J Exp Pathol       Date:  1992-04       Impact factor: 1.925

4.  Thyroperoxidase immunodetection for the diagnosis of malignancy on fine-needle aspiration of thyroid nodules.

Authors:  J F Henry; A Denizot; A Porcelli; M Villafane; P Zoro; S Garcia; C De Micco
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

5.  CD26 (Dipeptidyl Aminopeptidase IV) Expression in Normal and Diseased Human Thyroid Glands.

Authors:  Marcus A. Lima; Valeria A. Gontijo; Fernando C. L. Schmitt
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

6.  Expression of adhesion molecule ICAM-1 (CD54) in thyroid papillary adenocarcinoma.

Authors:  M Nakashima; K Eguchi; N Ishikawa; I Yamashita; M Sakai; H Ida; Y Kawabe; K Ito; S Nagataki
Journal:  J Endocrinol Invest       Date:  1994-12       Impact factor: 4.256

7.  Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV.

Authors:  C de Micco; V Savchenko; R Giorgi; F Sebag; J-F Henry
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

Review 8.  CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation.

Authors:  S Iwata; C Morimoto
Journal:  J Exp Med       Date:  1999-08-02       Impact factor: 14.307

9.  Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.

Authors:  Murray J Cutler; Erica L Lowthers; Cynthia L Richard; Dagmar M Hajducek; Paul A Spagnuolo; Jonathan Blay
Journal:  BMC Cancer       Date:  2015-11-10       Impact factor: 4.430

10.  Dipeptidyl peptidase 10, a novel prognostic marker in colorectal cancer.

Authors:  Heae Surng Park; Hyun Yang Yeo; Hee Jin Chang; Kyung-Hee Kim; Ji Won Park; Byung Chang Kim; Ji Yeon Baek; Sun Young Kim; Dae Yong Kim
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.